Citi starts ArriVent stock with buy rating citing promising lung cancer drug
© Reuters. Tuesday, Citi initiated coverage on ArriVent BioPharma (NASDAQ:AVBP) with a Buy rating and a price target of $30.00. ...
Friday, January 31, 2025
Tag: Cancer
EY: Health Executives Are Implementing Digital Health, But Aren’t Seeing ROI Yet
Following the Covid-19 pandemic, there has been a boom in the digital health space. But health executives aren’t seeing the ...
Elation Health’s New Integration Brings Drug Pricing Transparency to the Point of Care for PCPs
For U.S. consumers, the pharmacy can sometimes be a bit of a scary place. Many Americans have been hit with ...
Firefly Bio Unveils $94M to Illuminate the Startup’s New Take on ADC Cancer Meds
The class of cancer therapies known as antibody drug conjugates showed toxic drug payloads can be delivered to tumors in ...
AI Biotech Exscientia Fires CEO Hopkins for Relationships With Two Employees
Exscientia founder and CEO Andrew Hopkins is out of a job after an investigation found the CEO engaged in relationships ...
Supporting innovations in cancer treatment and prevention for our nation’s most vulnerable
By KAT MCDAVITT and LESLIE KIRK Innsena has made a $100,000 contribution to CancerX, making Innsena the public-private partnership’s first ...
With wigs, eyebrow restoration and nipple tattoos, this project helps cancer patients feel like women again
After Shelby, a 30-year-old schoolteacher in New York, finished chemotherapy treatment last year for breast cancer, she hardly recognized herself ...
“The Name May Be ‘Neue’ but Their Problems are Old”: Will Bright Health’s Rebrand Save It?
When insurtech Bright Health Group first emerged back in 2015, it had bold goals of disrupting the insurance industry by ...
Everly Health Partners With National Kidney Foundation, Expands Kidney Health Testing Suite
Everly Health is teaming up with the National Kidney Foundation to improve education around chronic kidney disease, the company announced ...
Biocon inks pact with Sandoz for sale of 2 biosimilar products in Australia
Biocon Biologics on Friday said it has inked a five-year pact with pharmaceutical company Sandoz AG regarding the sale ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.